Sutro Biopharma, Inc.
STRO
FAIR PRICE VALUATION
Updated daily
Model: DCF 50% · Relative 30% · Consensus 20%
MARKET PRICE
$25.81
FAIR PRICE
$23.50
MARGIN
$2.31
P/E Ratio
N/A
Div. Yield
N/A
ROE
275.3%
Exceptional
Market Cap
$212M
Small-cap
COMING SOON
Get notified when STRO's fair price changes
Fair Price Index app is launching soon with push notifications when valuations shift for stocks you follow.
iOS and Android · Free tier available
KEY FACTS
CEO
Jane Chung
COUNTRY
US
HEADQUARTERS
South San Francisco
SECTOR
Healthcare
EXCHANGE
NASDAQ
METHODOLOGY
How we calculate STRO's fair price
Sutro Biopharma, Inc.'s fair price of $23.50 is derived from a blended model that combines DCF analysis (50%), relative valuation against Healthcare peers using metrics like P/E and EV/EBITDA (30%), and analyst consensus (20%). At the current market price of $25.81, STRO trades 9.0% above its calculated fair value.
DCF MODEL · 50%
Discounted free cash flow analysis based on projected cash flows, discounted at a rate reflecting STRO's risk profile.
RELATIVE · 30%
Comparing STRO's valuation multiples against Healthcare peers to determine if the stock is over or undervalued relative to its industry.
ANALYST · 20%
Aggregated analyst price targets for STRO, weighted by recency and analyst accuracy.
TRY IT YOURSELF
Want to test your own assumptions? Use our free calculators to estimate STRO's fair value with your own inputs.
LEARN MORE
POWERED BY BULIOS
Get full analysis, financials, and AI insights for STRO.
Explore on BuliosFAQ
What is the fair price of STRO?+
Based on our blended model combining DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%), the fair price for Sutro Biopharma, Inc. is $23.50. At the current market price of $25.81, STRO trades 9.0% above its calculated fair value.
Is STRO overvalued or undervalued?+
Sutro Biopharma, Inc. is currently fair based on our valuation model. The stock trades at $25.81, which is 9.0% above the fair price of $23.50.
How often is STRO's fair price updated?+
We update fair price calculations for STRO daily after market close. The current fair price of $23.50 incorporates the latest market data and sector multiples.
What factors affect STRO's fair price calculation?+
STRO's fair price of $23.50 is derived from DCF analysis (50% weight), relative valuation against Healthcare peers (30% weight), and analyst consensus (20% weight)., ROE of 275.3%.
Is STRO a good buy right now?+
At $25.81, STRO trades 9.0% above our fair value estimate of $23.50. The stock is currently fair. ROE stands at 275.3% (exceptional). Fair Price Index provides valuation data — always do your own research before investing.
Does STRO pay dividends?+
STRO does not currently pay a dividend.
RELATED STOCKS
Fair Price Index is for informational purposes only and does not constitute investment advice. Fair value calculations are model-based estimates and may not reflect actual market conditions. Always conduct your own research before making investment decisions.